Wells Fargo lowers Synchrony target to $88

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Wells Fargo analyst Donald Fandetti maintained an Overweight rating on Synchrony Financial but lowered the price target to $88 from $95, following RBC Capital's earlier reduction to $80. Synchrony reported Q2 net earnings of $885 million and record purchase volume of $50 billion, while raising its full-year EPS guidance to $9.25–$9.50.

powered bylight_fuzz_icon
46194611

*this image is generated using AI for illustrative purposes only.

Wells Fargo analyst Donald Fandetti has maintained an Overweight rating on Synchrony Financial and lowered the price target to $88 from $95. This adjustment follows a similar move by RBC Capital, which previously reduced its target to $80 while maintaining a Sector Perform rating. The revised targets suggest a more cautious outlook on the company's near-term trajectory despite its operational performance.

Recent Financial Performance

Synchrony Financial reported net earnings of $885 million, or $2.59 per diluted share, for the second quarter. The company achieved an all-time high purchase volume of almost $50 billion, an 8% increase year-over-year. Net interest income rose 2% to $4.6 billion, while the net interest margin expanded 30 basis points to 15.08%. Ending loan receivables grew 2% to $102 billion.

Strategic Developments

The firm renewed or added over 15 partners, including Suzuki Motor and AmeriVet, during the quarter. Co-branded cards represented 52% of total purchase volume, rising 23% compared to the prior year. Synchrony also completed the acquisition of the Lowe's Pro Rewards American Express Card portfolio in April.

Capital Allocation and Guidance

Synchrony returned $950 million to shareholders through $850 million in share repurchases and $100 million in dividends. The company raised its full-year diluted earnings per share guidance to a range of $9.25 to $9.50. It anticipates mid-single-digit growth in ending loan receivables and expects net charge-offs to remain below 5.5% for the full year.

Key Financial Metrics

Metric Q2 2026 Value Change
Net Earnings $885 million —
Diluted EPS $2.59 —
Purchase Volume ~$50 billion +8% YoY
Net Interest Income $4.6 billion +2% YoY
Net Interest Margin 15.08% +30 bps YoY
Ending Loan Receivables $102 billion +2% YoY
Return on Average Assets 2.9% —
Return on Tangible Common Equity 25.2% —
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors are driving the cautious near-term outlook despite the record purchase volume?

How will the recent acquisition of the Lowe's Pro Rewards portfolio impact Synchrony's market position?

What risks could cause net charge-offs to exceed the anticipated 5.5% threshold?

like19
dislike

HSBC raises Synchrony Financial price target to $97

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

HSBC analyst Saul Martinez maintains a Buy rating on Synchrony Financial, raising the price target to $97 from $93 based on an updated valuation outlook.

powered bylight_fuzz_icon
45515362

*this image is generated using AI for illustrative purposes only.

HSBC analyst Saul Martinez has maintained a Buy rating on Synchrony Financial, raising the price target to $97 from the previous $93. The adjustment reflects an updated outlook on the company's valuation and market position.

Rating and Price Target

The research note highlights confidence in Synchrony Financial's performance trajectory. The revised price target of $97 suggests potential upside from current trading levels.

Metric Value
Rating Buy
Previous Price Target $93
New Price Target $97

The analyst's endorsement underscores a positive sentiment toward the firm's strategic direction and financial health.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove the $4 increase in the price target?

How might Synchrony's market position evolve in the current economic climate?

What are the potential risks to achieving the revised price target?

like16
dislike

More News on Synchrony Financial